The drug industry spends billions each year to promote its medicines to the masses, blanketing popular TV shows and magazines with ads. Now, digital companies are increasingly trying to pry away a share of that money for ads that target specific patients, rather than broad demographics.
Targeted ads are nothing new in retail; anyone who uses the internet has had the eerie feeling that the ads popping up on page after page appear to be aimed directly at them. But drug makers have long steered clear of many such tools, for fear of violating patient privacy law.
That’s changing now. Facebook and the music streaming service Pandora are aggressively vying for pharma dollars by promising to help drug makers identify and reach the users most likely to have certain diseases or conditions — without violating the privacy law known as HIPAA.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect